サマリー

レノックス・ガストー症候群治療の世界市場 2022-2026 年
Technavioはレノックス・ガストー症候群治療市場を監視しており、2022-2026年の間に6億8475万ドル、予測期間中にCAGR4.42%で加速して成長すると予測しています。当レポートでは、レノックス・ガストー症候群治療市場の全体分析、市場規模・予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、LGSのリスク要因を持つ人口の増加、LGSに対する認知度の向上、希少疾病用医薬品（オーファンドラッグ）の指定によって牽引されています。
レノックス・ガストー症候群治療市場の分析には、タイプ別セグメントと地理的展望が含まれます。
Technavioのレノックス・ガストー症候群治療薬市場は、以下のようにセグメント化されています。
タイプ別
- 非外科的治療
- 外科的治療
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本研究では、今後数年間のレノックス・ガストー症候群治療市場の成長を促進する主要な理由の一つとして、植物化学物質の導入が挙げられます。また、外科的治療法の進歩や戦略的提携は、市場の大きな需要につながるでしょう。
Technavio社は、複数の情報源からのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。レノックス・ガストー症候群治療市場に関する当レポートの対象領域は以下の通りです。
- レノックス・ガストー症候群治療薬市場のサイジング
- レノックス・ガストー症候群治療薬市場予測
- レノックス・ガストー症候群治療市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、アクロン小児病院、Amneal Pharmaceuticals Inc、Aquestive Therapeutics Inc、Cedars-Sinai Health System、Cision Ltd、Eisai Co., Ltd.など、いくつかの主要レノックスガストー症候群治療市場ベンダーに関する詳細分析を提供しています。Ltd.、Epilepsy Foundation、GlaxoSmithKline Plc、Lupin Ltd、Sun Pharmaceutical Industries Ltd、Supernus Pharmaceuticals Inc、Teva Pharmaceutical Industries Ltd.、UCB SA、Upsher Smith Laboratories LLC、Viatris Inc、Johnson and Johnsonです。また、レノックス・ガストー症候群治療市場分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/vehicle-to-grid-chargers-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 24: Chart on Type - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
o 5.2 Comparison by Type
o Exhibit 26: Chart on Comparison by Type
o Exhibit 27: Data Table on Comparison by Type
o 5.3 Non-surgical treatment - Market size and forecast 2021-2026
o Exhibit 28: Chart on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
o 5.4 Surgical treatment - Market size and forecast 2021-2026
o Exhibit 32: Chart on Surgical treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Surgical treatment - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Surgical treatment - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Surgical treatment - Year-over-year growth 2021-2026 (%)
o 5.5 Market opportunity by Type
o Exhibit 36: Market opportunity by Type ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 40: Chart on Geographic comparison
o Exhibit 41: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 Canada - Market size and forecast 2021-2026
o Exhibit 66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 78: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 79: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 81: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 82: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 83: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 84: Matrix on vendor position and classification
o 10.3 Cedars-Sinai Health System
o Exhibit 85: Cedars-Sinai Health System - Overview
o Exhibit 86: Cedars-Sinai Health System - Business segments
o Exhibit 87: Cedars-Sinai Health System - Key offerings
o Exhibit 88: Cedars-Sinai Health System - Segment focus
o 10.4 Cision Ltd
o Exhibit 89: Cision Ltd - Overview
o Exhibit 90: Cision Ltd - Product / Service
o Exhibit 91: Cision Ltd - Key offerings
o 10.5 Eisai Co. Ltd.
o Exhibit 92: Eisai Co. Ltd. - Overview
o Exhibit 93: Eisai Co. Ltd. - Business segments
o Exhibit 94: Eisai Co. Ltd. - Key offerings
o Exhibit 95: Eisai Co. Ltd. - Segment focus
o 10.6 Epilepsy Foundation
o Exhibit 96: Epilepsy Foundation - Overview
o Exhibit 97: Epilepsy Foundation - Product / Service
o Exhibit 98: Epilepsy Foundation - Key offerings
o 10.7 GlaxoSmithKline Plc
o Exhibit 99: GlaxoSmithKline Plc - Overview
o Exhibit 100: GlaxoSmithKline Plc - Business segments
o Exhibit 101: GlaxoSmithKline Plc - Key news
o Exhibit 102: GlaxoSmithKline Plc - Key offerings
o Exhibit 103: GlaxoSmithKline Plc - Segment focus
o 10.8 Johnson and Johnson
o Exhibit 104: Johnson and Johnson - Overview
o Exhibit 105: Johnson and Johnson - Business segments
o Exhibit 106: Johnson and Johnson - Key news
o Exhibit 107: Johnson and Johnson - Key offerings
o Exhibit 108: Johnson and Johnson - Segment focus
o 10.9 Supernus Pharmaceuticals Inc.
o Exhibit 109: Supernus Pharmaceuticals Inc. - Overview
o Exhibit 110: Supernus Pharmaceuticals Inc. - Product / Service
o Exhibit 111: Supernus Pharmaceuticals Inc. - Key offerings
o 10.10 Teva Pharmaceutical Industries Ltd.
o Exhibit 112: Teva Pharmaceutical Industries Ltd. - Overview
o Exhibit 113: Teva Pharmaceutical Industries Ltd. - Business segments
o Exhibit 114: Teva Pharmaceutical Industries Ltd. - Key news
o Exhibit 115: Teva Pharmaceutical Industries Ltd. - Key offerings
o Exhibit 116: Teva Pharmaceutical Industries Ltd. - Segment focus
o 10.11 UCB SA
o Exhibit 117: UCB SA - Overview
o Exhibit 118: UCB SA - Product / Service
o Exhibit 119: UCB SA - Key offerings
o 10.12 Upsher Smith Laboratories LLC
o Exhibit 120: Upsher Smith Laboratories LLC - Overview
o Exhibit 121: Upsher Smith Laboratories LLC - Product / Service
o Exhibit 122: Upsher Smith Laboratories LLC - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 123: Inclusions checklist
o Exhibit 124: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 125: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 126: Research methodology
o Exhibit 127: Validation techniques employed for market sizing
o Exhibit 128: Information sources
o 11.5 List of abbreviations
o Exhibit 129: List of abbreviations
o in the incidence rate


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Non-surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Non-surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Surgical treatment - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Surgical treatment - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Cedars-Sinai Health System - Overview
Exhibits86: Cedars-Sinai Health System - Business segments
Exhibits87: Cedars-Sinai Health System - Key offerings
Exhibits88: Cedars-Sinai Health System - Segment focus
Exhibits89: Cision Ltd - Overview
Exhibits90: Cision Ltd - Product / Service
Exhibits91: Cision Ltd - Key offerings
Exhibits92: Eisai Co. Ltd. - Overview
Exhibits93: Eisai Co. Ltd. - Business segments
Exhibits94: Eisai Co. Ltd. - Key offerings
Exhibits95: Eisai Co. Ltd. - Segment focus
Exhibits96: Epilepsy Foundation - Overview
Exhibits97: Epilepsy Foundation - Product / Service
Exhibits98: Epilepsy Foundation - Key offerings
Exhibits99: GlaxoSmithKline Plc - Overview
Exhibits100: GlaxoSmithKline Plc - Business segments
Exhibits101: GlaxoSmithKline Plc - Key news
Exhibits102: GlaxoSmithKline Plc - Key offerings
Exhibits103: GlaxoSmithKline Plc - Segment focus
Exhibits104: Johnson and Johnson - Overview
Exhibits105: Johnson and Johnson - Business segments
Exhibits106: Johnson and Johnson - Key news
Exhibits107: Johnson and Johnson - Key offerings
Exhibits108: Johnson and Johnson - Segment focus
Exhibits109: Supernus Pharmaceuticals Inc. - Overview
Exhibits110: Supernus Pharmaceuticals Inc. - Product / Service
Exhibits111: Supernus Pharmaceuticals Inc. - Key offerings
Exhibits112: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits113: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits114: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits115: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits116: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits117: UCB SA - Overview
Exhibits118: UCB SA - Product / Service
Exhibits119: UCB SA - Key offerings
Exhibits120: Upsher Smith Laboratories LLC - Overview
Exhibits121: Upsher Smith Laboratories LLC - Product / Service
Exhibits122: Upsher Smith Laboratories LLC - Key offerings
Exhibits123: Inclusions checklist
Exhibits124: Exclusions checklist
Exhibits125: Currency conversion rates for US$
Exhibits126: Research methodology
Exhibits127: Validation techniques employed for market sizing
Exhibits128: Information sources
Exhibits129: List of abbreviations